Walmart is rated a strong sell due to extreme overvaluation versus slow expected growth rates and cheaper peer metrics. WMT trades at historically high multiples—particularly its P/E of 40x—eclipsing ...

A new MIT study illustrates how areas within the brain’s executive control center tailor their messages in specific circuits with other brain regions to influence them with information about behavior ...

Gautam Adani delivers a powerful vision speech on how Bharat can reclaim its intellectual agency in the age of AI. Calling for a civilizational revival, Adani proposes five key missions—building the ...

For the past several years, America has been using its young people as lab rats in a sweeping, if not exactly thought-out, education experiment. Schools across the country have been lowering standards ...

Forbes contributors publish independent expert analyses and insights. Laia Farran Graves is a journalist and stylist specializing in luxury. A variety of strong jewelry styles have made their way down ...

A sharp rise in students entering the University of California system without middle school-level math skills is raising alarms among educators. A new internal report from the University of California ...

Does quantum mechanics really reflect nature in its truest form, or is it just our imprecise way of describing the weird properties of the very small? A famous test that can help answer this question ...

Decades of research has viewed DNA as a sequence-based instruction manual; yet every cell in the body shares the same genes – so where is the language that writes the memory of cell identities?

Applying drugstore mascara is a quick and easy way to lengthen the appearance of your lashes and make them look thicker and bolder. But sometimes, mascara just doesn’t cut it, am I right? Whether ...

VectorY Therapeutics has seen the shape of things to come—and it involves finding fresh ways to deliver its gene therapies into the brain. The Dutch biotech has secured an exclusive option to evaluate ...

Shape Therapeutics Inc. could bring in as much as $1.2 billion in a new option and license deal with Vectory Therapeutics BV. It’s another collaboration for both companies that are known for working ...